The Impact of Folic Acid in The Treatment of Major - Thalassemia

The Amount of Folic Acid and Homocysteine in Patients With Major Beta Thalassemia Recipient of Blood over 2 Years

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016011425989N2

Enrollment

Registered

2016-03-14

Start date

2015-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta Thalassemia. Thalassemia(anemia) (disease)- major D56.1

Interventions

In this study one milligram of folic acid supplements daily for patients already taking a number were cut off for a month. In this review we have one study group..

Treatment - Other

In this study one milligram of folic acid supplements daily for patients already taking a number were cut off for a month. In this review we have one study group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Patients over Two Years of Age with Thalassemia Major Blood Recipient who Received Folic Acid Supplements for at Least 6 Months Exclusion Criteria: Under two Years; Pregnant Women; Lactating Women

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum folic acid levels. Timepoint: Supplements before and one month after stopping it. Method of measurement: In terms of micrograms per liter and by chemiluminescence.;Serum homocysteine level. Timepoint: Supplements before and one month after stopping it. Method of measurement: In terms of micromoles per liter and by chemiluminescence.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Hajar.Hemmati

Medical Sciences of Guilan University

yasna.hemmati@gmail.com+98 333369019

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026